Literature DB >> 21176129

Meeting report: 3rd international workshop on insulin & cancer heidelberg, Germany, october 30-31, 2010.

Ernst Chantelau1, Doris Mayer.   

Abstract

The 3rd International Workshop on Insulin & Cancer was held on October 30-31, 2010 at the German Cancer Research Centre in Heidelberg/Germany. The topics followed-up the discussions of the previous workshops: possible differences in mitogenicity between natural insulin and genetically engineered insulin derivatives (insulin analogues), as shown by laboratory studies and epidemiologic studies alike; molecular studies on the links between metabolic and mitogenic effects of insulin, and of hyperinsulinaemia in particular; epidemiologic evidence of interferences between insulin and other hormones, particularly sex hormones, and obesity-associated cancer; the involvement of inflammatory cytokines produced by fat tissue in obesity-associated cancer; aspects of drug-design (binding drugs to albumin) and, last but not least, detection and investigation of circulating cancer cells.

Entities:  

Year:  2010        PMID: 21176129      PMCID: PMC3017020          DOI: 10.1186/1758-5996-2-73

Source DB:  PubMed          Journal:  Diabetol Metab Syndr        ISSN: 1758-5996            Impact factor:   3.320


  2 in total

Review 1.  Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?

Authors:  K Müssig; H Staiger; K Kantartzis; A Fritsche; L Kanz; H-U Häring
Journal:  Diabet Med       Date:  2011-03       Impact factor: 4.359

2.  Insulin-responsiveness of tumor growth.

Authors:  Ernst Chantelau
Journal:  Arch Physiol Biochem       Date:  2009-05       Impact factor: 4.076

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.